|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 96, 600-607, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
D Novitzky, PA Human and DK Cooper
Cardiopulmonary bypass is associated with a reduction in plasma free
triiodothyronine in patients undergoing cardiac operations. A previous
experimental study in pigs demonstrated a marked inotropic effect when
triiodothyronine was administered after a period of myocardial ischemia and
cardiopulmonary bypass; this was associated with a significant reduction in
mortality compared with the mortality in control pigs. To clarify the
effect of triiodothyronine on myocardial high energy phosphate stores and
lactate, a series of experiments was done in baboons undergoing 3 hours of
myocardial ischemia while supported by cardiopulmonary bypass. Seven
baboons received no triiodothyronine and six received 6 micrograms of
triiodothyronine at the end of the ischemic period. Seventy minutes after
cardiopulmonary bypass, the myocardial adenosine triphosphate level was
significantly higher (p less than 0.01) in the treated animals. In
untreated animals, a steady increase in myocardial lactate occurred after
cardiopulmonary bypass; by 120 minutes after ischemia (70 minutes after
cardiopulmonary bypass) there was a significant difference in lactate
levels between the two groups (p less than 0.01). We postulate that a
combination of global ischemia and depletion of triiodothyronine results in
reduced mitochondrial function, inhibition of the tricarboxylic acid cycle,
and increased anaerobic metabolism and depletion of myocardial phosphates.
Triiodothyronine replacement therapy leads to improved mitochondrial
function and increased aerobic metabolism, which results in increased
synthesis of myocardial phosphates. We suggest that there may be a place
for the administration of triiodothyronine in patients undergoing cardiac
operations with a prolonged myocardial ischemic period or in whom there is
any evidence of low cardiac output after discontinuation of cardiopulmonary
bypass.
ARTICLES
Effect of triiodothyronine (T3) on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass. An experimental study in baboons
Department of Cardiothoracic Surgery, University of Cape Town Medical School, Republic of South Africa.
This article has been cited by other articles:
![]() |
M. A. Portman, K. Qian, J. Krueger, and X.-H. Ning Direct action of T3 on phosphorylation potential in the sheep heart in vivo Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2484 - H2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bartkowski, M. Wojtalik, E. Korman, G. Sharma, J. Henschke, and W. Mrowczynski Thyroid hormones levels in infants during and after cardiopulmonary bypass with ultrafiltration Eur J Cardiothorac Surg, December 1, 2002; 22(6): 879 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. DiPierro, J. E. Bavaria, E. B. Lankford, D. J. Polidori, M. A. Acker, J. T. Streicher, and T. J. Gardner Triiodothyronine Optimizes Sheep Ventriculoarterial Coupling for Work Efficiency Ann. Thorac. Surg., September 1, 1996; 62(3): 662 - 669. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr, and F. G. Spinale 3,5,3' triiodo-L-thyronine pretreatment with cardioplegic arrest and chronic left ventricular dysfunction Ann. Thorac. Surg., August 1, 1995; 60(2): 292 - 299. [Abstract] [PDF] |
||||
![]() |
J. D. Walker, F. A. Crawford, and F. G. Spinale PRETREATMENT WITH 3,5,3' TRIIODO-L-THYRONINE (T3): Effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 315 - 327. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford, S. Kato, and F. G. Spinale The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and {beta}-adrenergic responsiveness in dilated cardiomyopathy J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 672 - 679. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr, R. Mukherjee, M. R. Zile, and F. G. Spinale Direct effects of acute administration of 3, 5, 3' triiodo-L-thyronine on myocyte function Ann. Thorac. Surg., September 1, 1994; 58(3): 851 - 856. [Abstract] [PDF] |
||||
![]() |
S. Buket, A. Alayunt, M. Ozbaran, A. Hamulu, B. Discigil, B. Cetindag, H. Ozkilic, Z. Balkan, O. Bilkay, and I. Durmaz Effect of pulsatile flow during cardiopulmonary bypass on thyroid hormone metabolism Ann. Thorac. Surg., July 1, 1994; 58(1): 93 - 96. [Abstract] [PDF] |
||||
![]() |
C. M. Dyke, M. Ding, A. S. Abd-Elfattah, K. Loesser, R. J. Dignan, A. S. Wechsler, and D. R. Salter Effects of triiodothyronine supplementation after myocardial ischemia Ann. Thorac. Surg., August 1, 1993; 56(2): 215 - 222. [Abstract] [PDF] |
||||
![]() |
S.-H. Chu, T.-S. Huang, R.-B. Hsu, S.-S. Wang, and C.-J. Wang Thyroid hormone changes cardiovascular surgery and clinical implications Ann. Thorac. Surg., October 1, 1991; 52(4): 791 - 796. [Abstract] [PDF] |
||||
![]() |
C. M. Dyke, T. Yeh Jr, J. D. Lehman, A. Abd-Elfattah, M. Ding, A. S. Wechsler, and D. R. Salter Triiodothyronine-enhanced left ventricular function after ischemic injury Ann. Thorac. Surg., July 1, 1991; 52(1): 14 - 19. [Abstract] [PDF] |
||||
![]() |
F. W. Holland II, P. S. Brown Jr, B. D. Weintraub, and R. E. Clark Cardiopulmonary bypass and thyroid function: A "euthyroid sick syndrome" Ann. Thorac. Surg., July 1, 1991; 52(1): 46 - 50. [Abstract] [PDF] |
||||
![]() |
R. E. Clark Triiodothyronine: To be or not to be, that is the question Ann. Thorac. Surg., January 1, 1991; 51(1): 5 - 5. [PDF] |
||||
![]() |
D. Novitzky, N. Matthews, D. Shawley, D. K. C. Cooper, and N. Zuhdi Triiodothyronine in the recovery of stunned myocardium in dogs Ann. Thorac. Surg., January 1, 1991; 51(1): 10 - 17. [Abstract] [PDF] |
||||
![]() |
J. K. Kirklin, J. Neves, D. C. Naftel, S. B. Digerness, J. W. Kirklin, and E. H. Blackstone Controlled initial hyperkalemic reperfusion after cardiac transplantation: Coronary vascular resistance and blood flow Ann. Thorac. Surg., April 1, 1990; 49(4): 625 - 631. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |